Empagliflozin improves left ventricular diastolic function in db/db mice without altering cardiac expression of enzymes relevant for ketone body or branched chain amino acid catabolism.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Targeting reverse remodelling in heart failure Pharmacotherapy ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by